We are live on
!
Find out more
United Therapeutics
UTHR
UTHR
707 hedge funds and large institutions have $17.2B invested in United Therapeutics in 2025 Q3 according to their latest regulatory filings, with 112 funds opening new positions, 211 increasing their positions, 286 reducing their positions, and 66 closing their positions.
New
Increased
Maintained
Reduced
Closed
89% more funds holding in top 10
Funds holding in top 10: 9 → 17 (+8)
70% more first-time investments, than exits
New positions opened: 112 | Existing positions closed: 66
36% more capital invested
Capital invested by funds: $12.6B → $17.2B (+$4.54B)
6% more funds holding
Funds holding: 670 → 707 (+37)
6.64% less ownership
Funds ownership: 97.48% → 90.85% (-6.6%)
26% less repeat investments, than reductions
Existing positions increased: 211 | Existing positions reduced: 286
51% less call options, than puts
Call options by funds: $622M | Put options by funds: $1.27B
Holders
707
Holders Change
+37
Holders Change %
+5.52%
% of All Funds
9.28%
Holding in Top 10
17
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+88.89%
% of All Funds
0.22%
New
112
Increased
211
Reduced
286
Closed
66
Calls
$622M
Puts
$1.27B
Net Calls
-$644M
Net Calls Change
-$673M
Top Buyers
| 1 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$252M |
| 2 |
Citigroup
New York
|
+$171M |
| 3 |
EP
Eversept Partners
New York
|
+$65.2M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$62.7M |
| 5 |
Millennium Management
New York
|
+$61M |
